Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin

Anthony P. Cardile, Heather Briggs, S. Rodrigo Burguete, Monica Herrera, Brian L. Wickes, James H. Jorgensen

Producción científica: Articlerevisión exhaustiva

7 Citas (Scopus)

Resumen

Carbapenem-resistant Enterobacteriaceae infections are becoming more common, are associated with high mortality rates, and are difficult to treat due to multiple mechanisms of resistance. We describe the successful treatment of Klebsiella pneumoniae carbapenemase-expressing Enterobacter cloacae empyema in a lung transplant recipient with cefepime and levofloxacin.

Idioma originalEnglish (US)
Páginas (desde-hasta)199-200
Número de páginas2
PublicaciónDiagnostic Microbiology and Infectious Disease
Volumen78
N.º2
DOI
EstadoPublished - feb 2014

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Huella

Profundice en los temas de investigación de 'Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin'. En conjunto forman una huella única.

Citar esto